Items where Author is "Bordbar, M."
 | Up a level |
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 2.
Article
(2025) A randomized, two-armed, double-blind, single-dose, cross-over, bioequivalence clinical trial to compare pharmacokinetic parameters and safety of recombinant human factor VIII with Fc fusion produced by AryoGen Pharmed Company versus Elocta® (reference product) in previously treated patients with severe haemophilia A. Annals of Hematology. pp. 1195-1202. ISSN 0939-5555
(2023) Patient and Physician Perspectives in the Management of Immune Thrombocytopenia in Iran: Responses from the ITP World Impact Survey (I-WISh). Clinical and Applied Thrombosis-Hemostasis. p. 14. ISSN 1076-0296